Objectives: Clinical efficacy of easily applicable peripheral nerve blocks has been in interest except open and closed surgical procedures requiring advanced equipment. We aimed to evaluate the clinical efficacy of triamcinolone and lidocaine injection for peripheral nerve branches in trigeminal neuralgia in terms of pain severity, pain frequency, and drug doses used. Methods: This study was a retrospective cohort study. A total of 72 patients with trigeminal neuralgia, who underwent peripheric trigeminal nerve injection with lidocaine and triamcinolone between 2011-2018 were included. Pain severity, pain frequency, changes in carbamazepine equivalent doses, and pregabalin equivalent doses were evaluated. We also evaluated whether there was a correlation between the success of the procedure and independent variables. Results: There was a statistically significant difference in pain intensity and frequency between baseline and post-procedure at 1, 3, and 6 mo (p=0.000). There was a statistically significant difference between carbamazepine equivalent doses at baseline, and 3, and 6 mo after the procedure (p=0.002, 0.005 respectively). Two complications were evaluated, 1 patient had prolonged painless paresthesia related to the procedure area lasting about 1 week and 2 patients had ecchymosis at the procedure area. Conclusion: The injection of lidocaine and corticosteroid combination for peripheral branches of the trigeminal nerve may result in short and mid-term clinical relief. Peripheral nerve blocks may be preferred for short-medium-term pain management with rare complications and simple device requirements also need little experience and skills.

No abstract

Objectives: The aim of this study was to evaluate the reliability and validity of the Turkish version of the Brief Pain Inventory (BPI-TR) in patients with cancer pain. Patients and methods: The study included 130 patients (70 females, 60 males; mean age: 56.1±13.3 years; range, 18 to 87 years) diagnosed with any type and stage of cancer between April 2017 and March 2018. Brief Pain Inventory, Pain Disability Index, EORTC QLQ C30 and Pain Management Index were used to collect data. The reliability of the scale was tested with `internal consistency` and its validity with `construct validity`. Cronbach`s alpha values of >0.70 were accepted as the threshold for internal consistency. Construct validity was tested in the context of structural validity with factor analysis and also tested in terms of convergent construct validity by investigating its correlation with the Pain Disability Index (PDI) and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Results: The internal consistency of pain severity and pain-related interference was found as 0.91 and 0.95, respectively. The alpha coefficient was found to be between 0.795 and 0.873 for the pain severity index and between 0.729 and 0.861 for the pain-related interference index. There was a clear link between the BPI-TR pain severity index and the ninth question in the EORTC QLQ-C30 (rho=0.66, p<0.05). The association between the BPI-TR interference index and the 19th question in the EORTC QLQ-C30 was also strong (rho=0.77, p<0.05). The correlation between the BPI-TR interference index and the PDI was found to be moderate (rho=0.50, p<0.05). Conclusion: The BPI-TR was found to be a reliable and legitimate tool to evaluate cancer pain in the Turkish population.

Aim: Work-related musculoskeletal disorders and associated musculoskeletal pain among intensive care nurses are important, as these factors may be related to presenteeism and work engagement. The aim of this study was to investigate the potential association of musculoskeletal pain with presenteeism and work engagement among intensive care nurses. Material and Method: This descriptive study was carried out with members of the Turkish Society of Critical Care Nurses. All the participants completed a questionnaire, which included questions about general demographic data and occupational musculoskeletal exposures (Occupational Safety and Health Administration [OSHA] Ergonomic Assessment Checklist). To measure pain, work engagement and presenteeism, the following instruments were used: The Brief Pain Inventory Short Form (BPI SF), Utrecht Work Engagement Scale (UWES-17) and Stanford Presenteeism Scale-6 (SPS-6). This study was performed in 2021, and the questionnaire was distributed via email to the database of Turkish Society of Critical Care Nurses. Results: Our study was completed with 153 intensive care unit nurses. Among the study population, 76.5% (n=117) of the nurses had chronic musculoskeletal pain, 80% of whom had exposure to lifting heavy weights. There was a weak negative correlation between pain and work engagement, as shown by the BPI SF pain interference subscale and the vigour subscale of the UWES-17 (p=0.04, r=-.166). There was also a weak negative correlation between pain and presenteeism according to the BPI SF pain interference subscale and SPS-6 (p=0.04, r=-.193). There was no statistically significant association between workplace ergonomic exposures, presenteeism, work engagement and the presence of chronic musculoskeletal pain. Conclusion: Neither chronic musculoskeletal system pain nor pain intensity was significantly correlated with work engagement, occupational musculoskeletal exposures or presenteeism. However, musculoskeletal pain-related effects on daily activities of living had a negative impact on work engagement (vigour) and presenteeism.